Hemoglobin sickle cell disease complications: A clinical study of 179 cases

Haematologica

Volumn 97, Issue 8, 2012, Pages 1136-1141

  Lionnet, François ^a   Hammoudi, Nadjib ^b   Stojanovic, Katia Stankovic ^a   Avellino, Virginie ^a   Grateau, Gilles ^c   Girot, Robert ^c   Haymann, Jean Philippe ^a  

^a HÔPITAL TENON   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Anemia; Hemoglobin SC disease; Hyperviscosity; Nephropathy; Otologic disorders; Phlebotomy; Pulmonary arterial hypertention; Retinopathy; Sickle cell anemia

Indexed keywords

ALBUMIN; HEMOGLOBIN; HYDROXYUREA;

ACUTE CHEST SYNDROME; ADULT; AGED; ARTERY THROMBOSIS; ARTICLE; BLOOD VESSEL OCCLUSION; BONE NECROSIS; CLINICAL ASSESSMENT; DOPPLER FLOWMETRY; ECHOCARDIOGRAPHY; FEMALE; GLOMERULUS FILTRATION RATE; HEMOGLOBIN SC DISEASE; HUMAN; KIDNEY DISEASE; KIDNEY PAPILLA NECROSIS; LEG ULCER; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PERCEPTION DEAFNESS; PHLEBOTOMY; PREVALENCE; PRIAPISM; PULMONARY HYPERTENSION; RETINOPATHY; SICKLE CELL ANEMIA; STROKE; TRANSFUSION; VENOUS THROMBOEMBOLISM;

ADOLESCENT; ADULT; AGED; ANEMIA, SICKLE CELL; FEMALE; HEMOGLOBINS; HUMANS; HYPERTENSION, PULMONARY; KIDNEY DISEASES; MALE; MIDDLE AGED; PHLEBOTOMY; PREVALENCE; YOUNG ADULT;

EID: 84864806084     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2011.055202     Document Type: Article

References (41)

1. Weatherall DJ. The inherited diseases of hemoglobin are an emerging global health burden. Blood. 2010;115(22):4331-6.
2. Bunn HF, Noguchi CT, Hofrichter J, Schechter GP, Schechter AN, Eaton WA. Molecular and cellular pathogenesis of hemoglobin SC disease. Proc Natl Acad Sci. 1982;79(23):527-31.
3. Ballas SK, Lewis CN, Noone AM, Krasnow SH, Kamarulzaman E, Burka ER. Clinical, Hematological, and Biochemical Features of Hb SC Disease. Am J Hematol 1982; 13(1):37-51.
4. Haymann JP, Stankovic K, Levy P, Avellino V, Tharaux PL, Letavernier E, et al. Glomerular hyperfiltration in adult sickle cell anemia: a frequent hemolysis associated feature. Clin J Am Soc Nephrol. 2010; 5(5):756-61.
5. Gladwin MT, Sachdev V, Jison ML, Shizukuda Y, Plehn JF, Minter K, et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med. 2004;350(9):886-95.
6. Powars DR, Hiti A, Ramicone E, Johnson C, Chan L. Outcome in hemoglobin SC disease: a four-decade observational study of clinical, hematologic, and genetic factors. Am J Hematol. 2002; 70(3):206-15.
7. Nagel RL, Fabry ME, Steinberg MH. The paradox of hemoglobin SC disease. Blood Rev. 2003;17(3):167-78.
8. Koduri PR, Agbemadzo B, Nathan S. Hemoglobin S-C disease revisited: clinical study of 106 adults. Am J Hematol. 2001; 68(4):298-300.
9. River GL, Robbins AB, Schwartz S0. S-C Hemoglobin: a clinical study. Blood. 1961; 18:385-416.
10. Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, et al. Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of Echocardiography: endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2010;23(7):685-713.
11. Koshy M, Entsuah R, Koranda A, Kraus AP, Johnson R, Bellvue R, et al. Leg ulcers in patients with sickle cell disease. Blood. 1989;74(4):1403-8.
12. Milner PF, Kraus AP, Sebes JI, Sleeper LA, Dukes KA, Embury SH, et al. Sickle cell disease as a cause of osteonecrosis of the femoral head. N Engl J Med. 1991;325(21): 1476-81.
13. Downes SM, Hambleton IR, Chuang EL, Lois N, Serjeant GR, Bird AC. Incidence and natural history of proliferative sickle cell retinopathy. Ophthalmology. 2005; 112(11):1869-75.
14. Burch-Sims GP, Matlock VR. Hearing loss and auditory function in sickle cell disease. J Commun Disord. 2005;38(4):321-9.
15. Gould HJ, Crawford MR, Smith WR, Beckford N, Gibson, WR, Pettit L, et al. Hearing disorders in sickle cell disease: Cochlear and retrocochlear findings. Ear Hear. 1991;12(5):352-4.
16. Onakoya PA, Nwaorgu OG, Shokunbi WA. Hearing impairment in persons with the hemoglobin SC genotype. Ear Nose Throat J. 2010;89(7):306-10.
17. Crawford MR, Gould HJ, Smith WR, Beckford N, Gibson WR, Bobo L. Prevalence of hearing loss in adults with sickle cell disease. Ear Hear. 1991;12(5): 349-51.
18. Kato GJ, Gladwin MT, Steinberg MH. Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Reviews. 2007;21(1):37-47.
19. Guasch A, Navarrete J, Nass K, Zayas CF. Glomerular involvement in adults with sickle cell hemoglobinopathies. Prevalence and clinical correlates of progressive renal failure. J Am Soc Nephrol. 2006;17(8):2228-35.
20. Schmitt F, Martinez F, Brillet G, Giatras I, Choukroun G, Girot R, et al. Early glomerular dysfunction in patients with sickle cell anemia. Am J Kidney Dis. 1998;32(2):208-14.
21. Thompson J, Reid M, Hambleton I, Serjeant GR. Albuminuria and renal function in homozygous sickle cell disease. Arch Intern Med. 2007;167(7):701-8.
22. Derebail VK, Nachman PH, Key NS, Ansede H, Falk RJ, Kshirsagar AV. High prevalence of sickle cell trait in African Americans with ESRD. J Am Soc Nephrol. 2010;21(3):413-7.
23. Gordeuk VR, Sachdev V, Taylor JG, Gladwin MT, Kato G, Castro OL. Relative systemic hypertension in patients with sickle cell disease is associated with risk of pulmonary hypertension and renal insufficiency. Am J Hematol. 2007;83(1):15-8.
24. Johnson CS. Arterial blood pressure and hyperviscosity in sickle cell disease. Hematol Oncol Clin N Am. 2005;19(5):827-37.
25. Parent F, Bachir D, Inamo J, Lionnet F, Driss F, Loko G, et al. A hemodynamic study of pulmonary hypertension in sickle cell disease. N Engl J Med. 2011;365(1):44-53.
26. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. 1994; 330(23):1639-44.
27. Manci EA, Culberson DE, Yang YM, Gardner TM, Powell R, Haynes J, et al. Causes of death in sickle cell disease: an autopsy study. Br J Haematol. 2003;123(2): 359-65.
28. Hassell KL, Eckman JR, Lane PA. Acute multiorgan failure syndrome: a potentially catastrophic complication of severe sickle cell pain episodes. Am J Med. 1994;96(2): 155-62.
29. Koduri PR. Iron in sickle cell disease: a review why less is better. Am J Hematol. 2003;73(1):59-63.
30. Haddy TB, Castro O. Overt iron deficiency in sickle cell disease. Arch Intern Med. 1982;142(9):1621-4.
31. McCurdy PR, Sherman AS. Irreversibly Sickled Cells and Red Cell Survival in Sickle Cell Anemia. A Study with Both DF3P and 51CR. Am J Med. 1978;64(2):253-8.
32. McCurdy PR, Mahmood L, Sherman AS. Red cell life span in sickle cell-hemoglobin C disease with a note about sickle cellhemoglobin O ARAB. Blood. 1975;45(2): 273-9.
33. Kato GJ, McGowan V, Machado RF, Little JA, Taylor J 6th, Morris CR, et al. Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood. 2006;107(6):2279-85.
34. Hebbel RP. Reconstructing sickle cell disease: A data-based analysis of the "hyperhemolysis paradigm" for pulmonary hypertension from the perspective of evidencebased medicine. Am J Hematol. 2011;86(2): 123-54.
35. Salman EK, Haymond MW, Bayne E, Sager BK, Wiisanen A, Pitel P, et al. Protein and energy metabolism in prepubertal children with sickle cell anemia. Pediatr Res. 1996;40(1):34-40.
36. Fabry ME, Kaul DK, Raventos-Suarez C, Chang H, Nagel RL. SC erythrocytes have an abnormally high intracellular hemoglobin concentration. Pathophysiological consequencies. J Clin Invest. 1982;70(6):1315-9.
37. Markham MJ, Lottenberg R, Zumberg M. Role of phlebotomy in the management of hemoglobin SC disease: case report and review of the literature. Am J Hematol. 2003;73(2):121-5.
38. Bouchaïr N, Manigne P, Kanfer A, Raphalen P, de Montalembert M, Hagege I, et al. Prevention of sickle cell crises with multiple phlebotomies. Arch Pediatr. 2000;7(3):249-55.
39. Rombos Y, Tzanetea R, Kalotychou V, Konstantopoulos K, Simitzis S, Tassiopoulos T, et al. Amelioration of painful crises in sickle cell disease by venesections. Blood Cells Mol Dis. 2002;28(2):283-7.
40. Castro O, Poillon WN, Finke H, Massac E, Kim BC. Improvement of sickle cell anemia by iron-limited erythropoiesis. Am J Hematol. 1994;47(2):74-81.
41. Ware RE. How I use hydroxyurea to treat young patients with sickle cell anemia. Blood. 2010;115(26):5300-11.